Advancing precision medicine across multiple fields
CELL THERAPY
IMU is at the forefront of accelerating cell therapy drug development processes. Leveraging our advanced immune analytics platform, we address critical development challenges such as donor selection, product characterisation, and patient stratification and monitoring. This integrated approach ensures a more efficient and effective development process to get cutting edge therapies to the right patients.
Immuno-oncology
IMU is dedicated to advancing the field of immuno-oncology by exploring the system-level immune signatures of cancer. Our focus encompasses the entirety of the patient journey, including early detection, precise patient stratification, and advanced monitoring for responses, toxicity, and potential relapse.
Transplantation
IMU is pioneering the use of innovative, systems-level immunological approaches for patient monitoring and the early detection of graft rejection. Our objective is to spearhead the development of the next generation of advanced diagnostic tools, setting new standards in medical technology and patient care.
Autoimmunity
IMU is at the cutting edge of medical innovation with its AI & ML powered analytics platform, designed to address critical challenges in the treatment of autoimmune disease. This includes the management of refractory diseases and the discovery of novel therapeutic targets. IMU is extending these advanced methodologies to novel research areas, including the study of psychosis, broadening the horizons of medical research and patient care.
